Table 2.
Sex, age, informativeness and clonality status of patients with GCT of’ bone determined by androgen receptor methylation specific PCR
| Subject & Number | Sex | Age (years) | Informativenessa | Polyclonalityb |
|---|---|---|---|---|
| RC 1 |
F | 43 | − | ? |
| BC 2 |
F | 41 | + | Yes |
| RE 3 |
F | 26 | + | Yes |
| BG 4 |
F | 30 | + | Yes |
| MH 5 |
F | 26 | + | Yes |
| DJ 6 |
F | 43 | + | Yes |
| VK 7 |
F | 40 | + | Yes |
| BL 8 |
F | 33 | + | Yes |
| NM 9 |
F | 63 | + | Yes |
| HP 10 |
F | 26 | + | Yes |
| BP 11 |
F | 12 | + | Yes |
| CR 12 |
F | 34 | + | Yes |
| AS 13 |
F | 22 | + | Yes |
| SS 14 |
F | 26 | + | Yes |
| MS 15 |
F | 25 | + | Yes |
| GT 16 |
F | 19 | + | Yes |
| RW 17 |
F | 23 | + | Yes |
a
Indicates heterozygosity for two alleles in normal tissue.
b
Two different X-chromosome alleles present in the tumor cells indicating polyclonal cellular proliferation. Standardization of human androgen receptor gene methylation specific PCR using densitometry ratio (expected) = 1.0.